Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

BMS's RYZ101 met its Phase 3 primary endpoint in GEP-NETs, raising immediate questions about radiopharmaceutical manufacturing scale-up ahead of a potential NDA.

Phio Pharmaceuticals releases first commercial-scale cGMP batch of PH-762 API, supporting Phase 2b trial initiation targeted for Q1 2027.

Lonza's exclusive deal with Qurient targets dual-payload ADC manufacturing, raising containment and process validation demands for CDMO operators.

Perceptive Discovery and Nucleus RadioPharma formalize a referral partnership to streamline radiopharmaceutical programs across the development continuum.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Oct 20
Oct 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
